Genentech
South San Francisco, Californiagene.com
Overview
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases . Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years . Genentech's transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Orionis Biosciences | May 2025 | Corporate Funding | Lead |
| Orionis Biosciences | Sep 2023 | Corporate Funding | Lead |
| Atalanta Therapeutics | Jan 2021 | Series A | Co-investor |
| Ribometrix | Jan 2021 | Strategic | Lead |
| LumaCyte | Aug 2019 | Grant | Co-investor |
Key People
KyungHyun Cho
Executive Director Of Frontier Research
Kenneth Berland
Principal Software Engineer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
